祥生医疗：股东莫若理及其一致行动人合计减持1.59%股份

Core Viewpoint - The announcement from Xiangsheng Medical indicates that shareholder Mo Ruoli has reduced his stake in the company, which does not affect the control or governance of the company [1] Shareholder Activity - Mo Ruoli reduced his holdings by 1.7831 million shares, representing 1.59% of the total share capital [1] - Following this reduction, Mo Ruoli and his concerted parties' shareholding decreased from 80.724 million shares to 78.9408 million shares, changing the ownership percentage from 71.99% to 70.40% [1] Impact on Company Control - The share reduction is part of a previously planned action and does not trigger a mandatory tender offer [1] - The reduction will not lead to changes in the controlling shareholder or actual controller, nor will it impact the company's governance and operations [1]